Breaking News
Digital IDs Just Went Live - Say Goodbye To Your Privacy & Money
The United States Is Buying Stocks (China's Playbook 2.0)
We have no other choice but to outright refuse and deny digital ID
Exactly. Get it yet?Top Tech News
3D Printed Aluminum Alloy Sets Strength Record on Path to Lighter Aircraft Systems
Big Brother just got an upgrade.
SEMI-NEWS/SEMI-SATIRE: October 12, 2025 Edition
Stem Cell Breakthrough for People with Parkinson's
Linux Will Work For You. Time to Dump Windows 10. And Don't Bother with Windows 11
XAI Using $18 Billion to Get 300,000 More Nvidia B200 Chips
Immortal Monkeys? Not Quite, But Scientists Just Reversed Aging With 'Super' Stem Cells
ICE To Buy Tool That Tracks Locations Of Hundreds Of Millions Of Phones Every Day
Yixiang 16kWh Battery For $1,920!? New Design!
Find a COMPATIBLE Linux Computer for $200+: Roadmap to Linux. Part 1
DARPA Nucleic Technology Funded to Get Virus Response to 1-60 Days
The P3 teams are developing technologies to deliver antibodies using nucleic acid technology, and achieve sufficient serum concentrations of the antibodies for protection against the pathogen within three days after administration.
DARPA has programs for Pandemic Prevention Platform, Nucleic Acids On-Demand Worldwide (NOW), and PReemptive Expression of Protective Alleles and Response Elements (PREPARE) programs.
Nucleic Acids On-Demand Worldwide (NOW)
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.